RALEIGH, NC / ACCESSWIRE / January 31, 2023 / 9 Meters Biopharma, Inc. (NASDAQ:NMTR), a clinical-stage company pioneering novel treatments for people with rare or
WHEATON, Ill.–( BUSINESS WIRE )–Veriti Management LLC (“Veriti”), a direct indexing asset technology company, today announced its rebrand as First Trust Direct Indexing, as well
Paychex CEO John Gibson joins ‘Squawk Box’ to discuss his vantage point view of the employment picture, the employment industry breakdown, and more.
BOCA RATON, Fla., Jan. 30, 2023 (GLOBE NEWSWIRE) — First Wave BioPharma, Inc. (NASDAQ:FWBI) (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing
The Station is a weekly newsletter dedicated to all things transportation. Sign up here — just click The Station — to receive the full edition of the newsletter
Roy Jakobs, CEO of Philips, discusses Q4 earnings for the company and the strategy to improve supply chain shortages and the overall company’s profitability.
SAN DIEGO , Jan. 30, 2023 /PRNewswire/ — Kintara Therapeutics, Inc. (Nasdaq: KTRA) (“Kintara” or the “Company”), a biopharmaceutical company focused on the development of
Highly experienced and accomplished three-time healthcare CEO with a proven track record of substantial value creation to lead MIMEDX
SOLANA BEACH, Calif. and REDWOOD CITY, Calif., Jan. 30, 2023 (GLOBE NEWSWIRE) — eFFECTOR Therapeutics, Inc. (NASDAQ: EFTR), a leader in the development of selective
ROSEMONT, Ill., Jan. 30, 2023 (GLOBE NEWSWIRE) — Wintrust Financial Corporation (“Wintrust” or “WTFC”) is today announcing the planned transition of the Chief Executive Officer